Filter
2304
Filtered Results: 2304
Text search:
controlled
drugs
Featured
Recommendations
264
New Publications
513
Language
Document type
No document type
1341
Guidelines
400
Studies & Reports
312
Manuals
117
Strategic & Response Plan
62
Fact sheets
32
Training Material
26
Situation Updates
6
Brochures
4
Resource Platforms
2
Infographics
2
Countries / Regions
India
171
Kenya
65
Global
63
South Africa
56
Western and Central Europe
46
Uganda
43
Ethiopia
40
Nigeria
38
Tanzania
34
Sierra Leone
33
Latin America and the Carribbean
32
Africa
31
Zambia
30
Nepal
29
Malawi
28
Ukraine
28
Ghana
26
Eastern Europe
26
Liberia
23
Rwanda
23
Philippines
22
Myanmar / Burma
22
Zimbabwe
20
Bangladesh
19
Colombia
17
Russia
17
Brazil
16
Syria
15
Indonesia
15
South–East Asia Region
15
Lesotho
14
Asia
13
South Sudan
12
Mozambique
11
Namibia
11
Eswatini/ Swaziland
11
Burkina Faso
10
Senegal
9
Argentina
9
Congo, Democratic Republic of
8
Botswana
8
Guinea
7
Cameroon
7
Germany
7
East and Southern Africa
7
Paraguay
7
Venezuela
7
Afghanistan
6
Yemen
6
Haiti
5
Lebanon
5
Thailand
5
Sudan
5
Bolivia
5
Eastern Europe and Central Asia
5
Tajikistan
5
Mali
4
USA
4
Iraq
4
Jordan
4
Chile
4
West and Central Africa
4
Middle East and North Africa
4
North America
4
Somalia
3
Pakistan
3
Cambodia
3
Central African Republic
3
Peru
3
Angola
3
Madagascar
3
Moldova
3
Iran
3
Georgia
3
Guinea-Bissau
2
Morocco
2
Saudi Arabia
2
Egypt
2
China
2
Benin
2
North Macedonia
2
Hungary
2
Ecuador
2
Libya
2
Mexico
2
Bhutan
2
Palestine
2
Albania
2
Laos
2
Canada
2
Lithuania
2
Kyrgyzstan
2
Vietnam
2
Jamaica
2
Côte d’Ivoire / Ivory Coast
1
Turkey
1
Singapore
1
Papua New Guinea
1
Serbia
1
Burundi
1
Greece
1
Sri Lanka
1
Western Pacific Region
1
Poland
1
Djibouti
1
Armenia
1
Timor Leste/ East Timor
1
Qatar
1
Romania
1
Australia
1
Kazakhstan
1
Gabon
1
Turkmenistan
1
Denmark
1
Mauritius
1
Tunisia
1
United Kingdom
1
Norway
1
Portugal
1
Azerbaijan
1
Authors & Publishers
Publication Years
Category
Countries
819
Clinical Guidelines
321
Public Health
156
Women & Child Health
105
Key Resources
55
Pharmacy & Technologies
29
Capacity Building
26
Protection & Security
1
Toolboxes
Mental Health
292
HIV
222
TB
205
COVID-19
113
AMR
90
Pharmacy
88
NCDs
87
NTDs
67
Caregiver
57
Rapid Response
49
Ebola
45
Conflict
35
Refugee
26
Disability
22
Planetary Health
21
Cholera
14
Global Health Education
14
Natural Hazards
13
Polio
10
Specific Hazards
6
Health Financing Toolbox
6
Zika
5
Social Ethics
2
These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w...
Cystic echinococcosis (CE) is a well-known neglected parasitic disease. However, evidence supporting the four current treatment modalities is inadequate, and treatment options remain controversial. The aim of this work is to analyse the available data to answer clinical questions regarding medical t...
Prepared as an outcome of ICMR Subcommittee on Buccal Mucosa Cancer | This consensus document on management of Buccal Mucosa cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. ...
Prepared as an outcome of ICMR Subcommittee on Cancer Cervix | This consensus document on management of cervix cancer summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It also interwe...
Full document available: https://www.icmr.nic.in/sites/default/files/guidelines/Gastric%20Cancer%20Final%20pdf%20for%20farrow_0.pdf | Prepared as an outcome of ICMR Subcommittee on Gastric Cancer | Coordinated by Division of Non Communicable Diseases | This Consensus Document on Management of Gastri...
Prepared as an outcome of ICMR Subcommittee on Larynx & Hypopharynx Cancers | This consensus document on management of larynx and hypopharynx cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and re...
Prepared as an outcome of ICMR Subcommittee on Non Hodgkin’s Lymphoma (High Grade) | This consensus document on management of non- hodgkin’s lymphoma – high grade summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molec...
The threat posed by antimicrobial resistance (AMR) to public health as well as global health security has been reiterated in umerous World Health Assembly (WHA) resolutions. AMR is also prioritized under the Global Health Security Agenda (GHSA), and India is one of the contributing countries. The Mi...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re...
This third booklet of the World Drug Report 2022 has a dual focus: opioids and cannabis.
The first chapter of the booklet provides an overview of opioids as a group of substances and their patterns of non-medical use at the global level. It also reviews the latest trends in the global supply of opi...
An Indicator-based Approach - This manual presents an indicator-based approach for rapidly assessing pharmaceutical management systems and programs. The manual contains a set of 46 indicators of performance, grouped under eight topics of pharmaceutical management, with each topic being covered by a ...
WHO Model Formulary for Children
recommended
WHO Model Formulary for children based on the Second Model List of Essential Medicines for Children 2009.
In 2007, the World Health Assembly passed a Resolution titled ‘Better Medicines for Children’. This resolution recognized the need for research and development into medicines for children,...
Provide guidance to HIV care practitioners on the optimal use of antiretroviral (ARV) agents for the treatment of HIV infection in adults and adolescents.
WHO GUIDELINES REVIEW COMMITTEE
Accessed 26 June 2014
